The IFITM5 mutation in osteogenesis imperfecta type V is associated with an ERK/SOX9-dependent osteoprogenitor differentiation defect
Journal of Clinical Investigation · 01.08.2024 · 134 (15)
DOI: 10.1172/jci170369 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 17.06.2024. Verfasst von Ronit Marom und 31 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA. Hauptthemen laut MEDLINE: Cell Differentiation, MAP Kinase Signaling System, Osteoblasts, Osteogenesis Imperfecta. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIGMS NIH HHS, NHLBI NIH HHS.
Abstract (Originalsprache)
Osteogenesis imperfecta (OI) type V is the second most common form of OI, distinguished by hyperplastic callus formation and calcification of the interosseous membranes, in addition to the bone fragility. It is caused by a recurrent, dominant pathogenic variant (c.-14C>T) in interferon-induced transmembrane protein 5 ( IFITM5 ). Here, we generated a conditional Rosa26- knockin mouse model to study the mechanistic consequences of the recurrent mutation. Expression of the mutant Ifitm5 in osteo-chondroprogenitor or chondrogenic cells resulted in low bone mass and growth retardation. Mutant limbs showed impaired endochondral ossification, cartilage overgrowth, and abnormal growth plate architecture. The cartilage phenotype correlates with the pathology reported in patients with OI type V. Surprisingly, expression of mutant Ifitm5 in mature osteoblasts caused no obvious skeletal abnormalities. In contrast, earlier expression in osteo-chondroprogenitors was associated with an increase in the skeletal progenitor cell population within the periosteum. Lineage tracing showed that chondrogenic cells expressing the mutant Ifitm5 had decreased differentiation into osteoblastic cells in diaphyseal bone. Moreover, mutant IFITM5 disrupted early skeletal homeostasis in part by activating ERK signaling and downstream SOX9 protein, and inhibition of these pathways partially rescued the phenotype in mutant animals. These data identify the contribution of a signaling defect altering osteo-chondroprogenitor differentiation as a driver in the pathogenesis of OI type V.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.
- Texas Children's Hospital, Houston, Texas, USA.
- Medical Scientist Training Program, Baylor College of Medicine, Houston, Texas, USA.
- Medical Scientist Training Program, UT Health Houston MD Anderson Cancer Center, Houston, Texas, USA.
- Department of Orthopaedic Surgery, McGovern Medical School at UT Health, Houston, Texas, USA.
- Department of Molecular and Cellular Biology, and Huffington Department of Education, Innovation, and Technology, Advanced Technology Cores, and.
Förderung
- NCI NIH HHS
- NIGMS NIH HHS
- NHLBI NIH HHS
- NIAMS NIH HHS
- NIDDK NIH HHS
- NIDCR NIH HHS
- NCRR NIH HHS
- NIH HHS
Zitieren
APA
Marom, R., Song, I. W., Busse, E. C., Washington, M. E., Berrier, A. S., Rossi, V. C., Ortinau, L., Jeong, Y., Jiang, M. M., Dawson, B. C., Adeyeye, M., Leynes, C., Lietman, C. D., Stroup, B. M., Batkovskyte, D., Jain, M., Chen, Y., Cela, R., Castellon, A., …, & Lee, B. H. (2024). The IFITM5 mutation in osteogenesis imperfecta type V is associated with an ERK/SOX9-dependent osteoprogenitor differentiation defect. Journal of Clinical Investigation, 134(15). https://doi.org/10.1172/jci170369
Vancouver
Marom R, Song IW, Busse EC, Washington ME, Berrier AS, Rossi VC, et al. The IFITM5 mutation in osteogenesis imperfecta type V is associated with an ERK/SOX9-dependent osteoprogenitor differentiation defect. Journal of Clinical Investigation. 2024;134(15). doi:10.1172/jci170369
BibTeX
@article{Marom2024,
author = {Marom, Ronit and Song, I-Wen and Busse, Emily C and Washington, Megan E and Berrier, Ava S and Rossi, Vittoria C and Ortinau, Laura and Jeong, Youngjae and Jiang, Ming-Ming and Dawson, Brian C and Adeyeye, Mary and Leynes, Carolina and Lietman, Caressa D and Stroup, Bridget M and Batkovskyte, Dominyka and Jain, Mahim and Chen, Yuqing and Cela, Racel and Castellon, Alexis and Tran, Alyssa A and Lorenzo, Isabel and Meyers, D Nicole and Huang, Shixia and Turner, Alicia and Shenava, Vinitha and Wallace, Maegen and Orwoll, Eric and Park, Dongsu and Ambrose, Catherine G and Nagamani, Sandesh Cs and Heaney, Jason D and Lee, Brendan H},
title = {The IFITM5 mutation in osteogenesis imperfecta type V is associated with an ERK/SOX9-dependent osteoprogenitor differentiation defect},
journal = {Journal of Clinical Investigation},
year = {2024},
volume = {134},
number = {15},
doi = {10.1172/jci170369}
}
EUVIMED